Which are 4 NZX penny stocks to explore ahead of 2022?

3 min read | November 24, 2021 04:00 PM NZDT | By Jasmine Anand

Highlights

  • Penny stocks often outperform their peers and give handsome returns to their investors when chosen wisely.
  • Savor published its interim results, highlighting its solid performance owing to the acquisition of three Hip group venues.
  • Rua Bioscience granted Callaghan Innovation Funding to strengthen its transformative research.

Investing in penny stocks tend to be lucrative for small traders and new entrants to stock markets, for these stocks are cheaply priced and do not burn a hole in pockets.

Moreover, these nano-stocks often evolve into high return stocks over a period of time, thus rewarding their investors.

That said, let us skim through the NZX penny stocks which ended the day’s session in green.

NZX penny stocks- NTL, SVR, RUA, RAD

Image source: © 2021 Kalkine Media, data source- EODHD/Others

New Talisman Gold Mines Limited (NZX:NTL)

New Talisman Gold Mines Limited has recently appointed Ms Samantha Sharif and Mr Michael Stiassny as its independent directors.

Meanwhile, Mr Calum McKenzie, who was on the Board on a temporary basis, has now resigned from the said position.

Which are 4 NZX penny stocks to explore ahead of 2022?

On 24 November, at the time of writing, New Talisman Gold Mines was flat at NZ$0.003.

Related Read: These 6 Stocks were Gainers and losers on the NZX today- NTL, IKE, MPG, CAV, NWF, MFB

Savor Limited (NZX:SVR)

Savor Limited has recently released its half-year results ended 30 September 2021, reporting an impressive performance that exceeded expectations.

Interesting Read: Do 5 NZX penny stocks have the potential to turn into multibaggers?

Owing to the acquisition of three Hip Group venues, the group revenue jumped to NZ$17.2 million.

Also, its operating earnings for the said period were recorded at NZ$2.1 million.

SVR took over a centralised distribution centre in June 2021. Further, it acquired Oji Sushi, which offers an affordable premium sushi range and established Bar Non Solo, reflecting the Group’s focus on its continued organic growth.

On 24 November, at the time of writing, Savor gained by 1.00% at NZ$0.495.

Rua Bioscience Limited (NZX:RUA)

Rua Bioscience Limited has been awarded Callaghan Innovation Funding of NZ$376,000 so as to support a project related to transformative research.

Related Read: Rua Bioscience (NZX:RUA) : Why did it receive Callaghan Innovation funding?

The said funding would strengthen RUA’s investment into the research project, which is crucial to the Company's quest to develop world-class medicinal cannabis products.

On 24 November, at the time of writing, Rua Bioscience was unchanged at NZ$0.395.

Radius Residential Care Limited (NZX:RAD)

Radius Residential Care Limited on 29 November will publish its half-year performance ended 30 September 2021.

It would be followed by a briefing for investors and analysts to be hosted by the management.

On 24 November, at the time of writing, Radius Residential Care was flat at NZ$0.500.

Do Read: Radius Residential (NZX:RAD) acquires Clare House, Waikiwi

Bottom Line

Penny stocks are comparatively cheaper than their peers; one can easily invest in these without losing any significant portion of one’s finance.


Disclaimer

The content on this website, including, but not limited to, any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (“Content”) is a service provided by Kalkine Media New Zealand Limited (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide financial advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests users seek financial advice from a financial advice provider, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all liability to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without any express or implied warranties of any kind. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit a source wherever it is indicated or is found to be necessary or desirable.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.